Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Haematologica|July 2, 2011
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalitiesLars Möllgård, Leonie Saft, Marianne Bach Treppendahl, et al.Genes, Chromosomes & Cancer|February 8, 2025
Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without LenalidomideBengt Rasmussen, Lars Nilsson, Magnus Tobiasson, et al.Anticancer Research|January 12, 2007
Reliability of the reported size of removed colorectal polypsCarlos A Rubio, Lars Grimelius, Johan Lindholm, et al.Annals of Hematology|May 21, 2017
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordanceLouise de Swart, Alex Smith, Marius MacKenzie, et al.Journal of Internal Medicine|August 8, 2022
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trialMartin Jädersten, Ingrid Lilienthal, Nikolaos Tsesmetzis, et al.Cytometry. Part B, Clinical Cytometry|November 23, 2022
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working groupWolfgang Kern, Theresia M Westers, Frauke Bellos, et al.Haematologica|October 21, 2016
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M Westers, Eline M P Cremers, Uta Oelschlaegel, et al.Cytometry. Part B, Clinical Cytometry|December 13, 2021
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working GroupArjan A van de Loosdrecht, Wolfgang Kern, Anna Porwit, et al.Cytometry. Part B, Clinical Cytometry|December 11, 2021
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNetVincent H J van der Velden, Frank Preijers, Ulrika Johansson, et al.Cytometry. Part B, Clinical Cytometry|December 20, 2022
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working GroupAnna Porwit, Marie C Béné, Carolien Duetz, et al.Pageof 4